Entourage Health Corp.
ETRGF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3% | -27.1% | 27.6% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 30.1% | 12.9% | 46.9% | -44% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -11.8% | -36.8% | 4.2% | -105.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -87.7% | -111.5% | -49.5% | -172.5% |
| EPS Diluted | -0.027 | -0.034 | -0.02 | -0.056 |
| % Growth | 19.1% | -64.2% | 63.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |